Screening for Risk Factors for the Development of Phlebitis After Intravenous Fluid Therapy in Children With Mycoplasma pneumoniae Pneumonia

Abstract

To investigate the risk factors for the occurrence of phlebitis after intravenous infusion therapy in children with Mycoplasma pneumoniae pneumonia. A total of 108 children with Mycoplasma pneumoniae pneumonia who received intravenous infusion therapy from December 2020 to December 2023 in our hospital were retrospectively analyzed. In the phlebitis group, the proportion of children with maximum body temperature ≥39℃ before treatment, the proportion of children with fever duration ≥3 days, and the proportion of children with combined pleural effusion were significantly higher (P < .05). Higher inflammation level before the initiation of treatment, longer duration of fever, and unsuccessful intravenous treatment are all risk factors for the occurrence of phlebitis in children with Mycoplasma pneumoniae pneumonia. Attention should be paid to the management of the whole process of intravenous infusion to reduce the incidence of this complication.